Key distinctions from growth hormone include [5] : Peptide lacks growth hormone receptor binding domains (specifically binding site 2) Binding site 2 is required for receptor dimerization and activation Competitive binding assays showed AOD9604 cannot compete with hGH for receptor binding Does not function as a growth hormone receptor antagonist Glucose Metabolism Preservation Unlike full hGH, which can induce insulin resistance and hyperglycemia, AOD9604 demonstrates no adverse effects on carbohydrate metabolism
You should have your IGF-1 level checked and a qualified doctor can use that information along with other tests and examination to prescribe the dose of growth hormone that is best for you
But the peptide therapies being touted online for their wellness and longevity benefits have not undergone large-scale, rigorous clinical trials involving humans
Therapy aims to induce and maintain disease remission to minimise gastrointestinal symptoms and risk of long-term disability, colectomy and colorectal cancer
COA sample BPC-157 Pentadecapeptide CHNO Batch ABL-BPC-2601 Appearance White lyophilized powder PASS Purity 99.42% PASS Mass check PASS Content check PASS Water content 4.8% PASS Salt profile PASS Endotoxin screen PASS Example batch record All specifications met Catalog records Active catalog SKUs
Appearance: White to off-white lyophilized powder in sterile vial
